Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > TLTFF- In good standing to challenge Merck’s Keytruda.

<< Previous

Bullboard Posts

Next >>

Comment by jmm1228on Sep 12, 2021 10:57am

253 Views

Post# 33846165

RE:RE:RE:TLTFF- In good standing to challenge Merck’s Keytruda.

The new COO/temp CEO's CV looks like that of a deal maker, not an operations chief. Amaybe a CEO but in Pharma?.

I think he was brought in to beat the bushes for a JV partner before TLT needs another round of financing.

Time will tell.

<< Previous

Bullboard Posts

Next >>

From now on, dynaCERT instead of Bitcoin or NVIDIA?